Potentially lifesaving implantable cardioverter defibrillators underutilized in eligible patients

September 7, 2017, Elsevier

Fewer than 10% of people who experience sudden cardiac arrest (SCA) outside of a hospital survive. Reoccurrence rates after an initial event are high, which is why current Canadian Cardiovascular Society, as well as other international guidelines, strongly recommend the use of implantable cardioverter defibrillators (ICDs) in selected patients who survive cardiac arrest. Despite this recommendation, a new study published in the Canadian Journal of Cardiology reveals that real-life ICD utilization rates are lower than expected.

Investigators analyzed medical records from over 1200 in the greater Toronto area who had survived an out of cardiac arrest. Subjects were deemed "likely ICD eligible" if they would have benefited from ICD implantation as defined by three parameters: having a shockable initial rhythm, no definite ischemia, and a good neurologic status. Out of patients who were assessed as "likely ICD eligible," only 57% received an ICD. Meanwhile, the implantation rate for "not likely ICD eligible" patients was 16.7%, while the overall implementation rate was 23.9%.

"This study illustrates that examining how medical care actually delivered in the 'real world' conforms to guidelines is vital in order to evaluate and improve care," explained lead investigator Paul Dorian, MD, MSc, Department Director, Division of Cardiology, University of Toronto and Staff Cardiac Electrophysiologist at St. Michael's Hospital. "Our findings are the first step in the process to improve the quality of care provided to these patients, by assessing if the right patients receive the right treatment. The next step should be to understand 'why', and to promote guideline-appropriate care."

While investigators acknowledged that it was unrealistic to expect the ICD implantation rate to be 100%, they had expected it to be higher than 57% in the eligible population. Researchers determined that the highest rate of one year post-cardiac arrest was among individuals who were ICD eligible, but who did not receive an ICD. Among patients who received an ICD, there were fewer deaths compared to those who did not.

ICD implantation capability of the admission hospital was found to be a significant predictor of whether or not a patient received an ICD. "There is insufficient information in this database to determine why this association exists, but some possible explanations include the absence of a local electrophysiology consultation service, perceived difficulty in access or transfer to implantation facilities, or differences in the specialty of the most responsible physician at the admission hospitals," noted Dr. Dorian. This treatment gap suggests that improved education and sensitization might be needed to avoid patients not receiving this potentially life-saving therapy simply because they have been managed in a hospital without specialized local expertise in the area.

Sudden cardiac death (SCD) as a result of is projected to be the number one cause of death worldwide by 2020. SCD is currently responsible for more life-years lost than all other leading causes of death, including individual cancers. ICDs can detect and stop the ventricular arrhythmias responsible for SCD, lowering the risk of death by more than 30%.

In an accompanying editorial, Ratika Parkash, MD, MS, and Anthony S. L. Tang, MD, offer some perspective on the impact of the results going forward: "This study highlights the importance of implementation of guidelines with knowledge translation programs that may assist in identifying truly eligible patients for both primary and secondary prevention ICDs, and thus providing this life-saving therapy where significant impact would occur on the rate of SCD in Canada."

Explore further: Are patients in rural areas being deprived of potentially lifesaving therapy?

More information: "Implantable Cardioverter Defibrillator Implantation Rates After Out of Hospital Cardiac Arrest: Are the Rates Guideline Concordant?" Canadian Journal of Cardiology, DOI: 10.1016/j.cjca.2017.05.013

"Editorial: Implantable Cardioverter Defibrillators in Sudden Cardiac Death Survivors: Are We Doing All We Can?" dx.doi.org/10.1016/j.cjca.2017.07.016).

Related Stories

Are patients in rural areas being deprived of potentially lifesaving therapy?

January 25, 2017
The implantable cardioverter defibrillator (ICD), a primary prevention device therapy, can help save the lives of patients suffering from heart failure or following a heart attack. Specialized heart function clinics often ...

Predictive models may help determine which patients benefit from ICDs

May 22, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter defibrillator (ICD), suggests a new study published today in the Journal of the American College of Cardiology. ...

Bag-mask ventilation fails to improve on endotracheal intubation in cardiac arrest

August 28, 2017
Bag-mask ventilation fails to improve on endotracheal intubation in out-of-hospital cardiac arrest patients, according to late-breaking results from the CAAM trial presented today in a Hot Line LBCT Session at ESC Congress.

New report outlines 10 measures for the prevention of sudden cardiac death

December 19, 2016
A new report presents 10 quality and performance measures that are intended to help stakeholders—including health systems, legislative bodies, and nongovernmental organizations, as well as healthcare practitioners, patients, ...

Study finds high survival rate for elderly patients with implantable defibrillator

January 16, 2017
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac arrest or a near-fatal arrhythmia, almost 80 percent survived two years—a higher rate than found in past ...

"Code blue" equals lower survival for cancer patients

August 2, 2017
Patients with advanced cancer who suffer cardiac arrest in the hospital have a survival rate of less than 10 percent—half the rate of other patients without cancer, according to a nationwide study led by the University ...

Recommended for you

The molecules that energize babies' hearts

June 14, 2018
A metabolic process that provides heart muscle with energy fails to mature in newborns with thickened heart walls, according to a Japan–Canada research team.

Tobacco aside, e-cigarette flavorings may harm blood vessels

June 14, 2018
Flavor additives used in electronic cigarettes and related tobacco products could impair blood vessel function and may be an early indicator of heart damage, according to new laboratory research in Arteriosclerosis, Thrombosis ...

Scientists identify enzyme responsible for vascular damage caused by aircraft noise

June 14, 2018
In a recent study, scientists at Johannes Gutenberg University Mainz (JGU) have identified an enzyme responsible for aircraft-related vascular damage. The researchers were also able to show that nighttime noise has a particularly ...

World-first test could predict risk of heart attack in coronary artery disease patients

June 14, 2018
Researchers have developed a world-first blood test which improves the prediction of the long-term risk of heart attack or death in those with severe coronary artery disease.

Surgical blood transfusions tied to clot risk

June 13, 2018
(HealthDay)—Blood transfusions around the time of surgery may raise your risk for dangerous blood clots, researchers say.

Massive study sheds light on the genetic roots of atrial fibrillation

June 12, 2018
Patients with atrial fibrillation (AF), a condition causing a rapid, irregular heart rate that can increase the risk of stroke, could use some new treatment options. Despite how common the condition is, the current treatment ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.